Abstract
Antibodies that recognize specific histone modifications are invaluable tools to study chromatin structure and function. There are numerous commercially available antibodies that recognize a remarkable diversity of histone modifications. Unfortunately, many of them fail to work in certain applications or lack the high degree of specificity required of these reagents. The production of affinity-purified polyclonal antibodies against histone modifications demands a little effort but, in return, provides extremely valuable tools that overcome many of the concerns and limitations of commercial antibodies. We present a series of protocols and guidelines for the production and use of large amounts of polyclonal antibodies that recognize modifications of canonical histones. Our protocols can be applied to obtain antibodies that occur in histone variants and proteins other than histones. In addition, some of our protocols are compatible with the production of monoclonal or recombinant antibodies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Brumbaugh J, Phanstiel D, Coon JJ (2008) Unraveling the histone’s potential: a proteomics perspective. Epigenetics 3:254–257
Egelhofer TA, Minoda A, Klugman S, Lee K, Kolasinska-Zwierz P, Alekseyenko AA et al (2010) An assessment of histone-modification antibody quality. Nat Struct Mol Biol 18:91–93
Fuchs SM, Strahl BD (2011) Antibody recognition of histone post-translational modifications: emerging issues and future prospects. Epigenomics 3:247–249
Nishikori S, Hattori T, Fuchs SM, Yasui N, Wojcik J, Koide A et al (2012) Broad ranges of affinity and specificity of anti-histone antibodies revealed by a quantitative peptide immunoprecipitation assay. J Mol Biol 424:391–399
Rothbart SB, Lin S, Britton LM, Krajewski K, Keogh MC, Garcia BA et al (2012) Poly-acetylated chromatin signatures are preferred epitopes for site-specific histone H4 acetyl antibodies. Sci Rep 2:489
Tjeertes JV, Miller KM, Jackson SP (2009) Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. EMBO J 28:1878–1889
Rothbart SB, Dickson BM, Raab JR, Grzybowski AT, Krajewski K, Guo AH et al (2015) An interactive database for the assessment of histone antibody specificity. Mol Cell 59:502–511
Guillemette B, Drogaris P, Lin HH, Armstrong H, Hiragami-Hamada K, Imhof A et al (2011) H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet 7, e1001354
Drogaris P, Villeneuve V, Pomies C, Lee EH, Bourdeau V, Bonneil E et al (2012) Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation. Sci Rep 2:220
Baker M (2015) Reproducibility crisis: blame it on the antibodies. Nature 521:274–276
Hirota T, Lipp JJ, Toh BH, Peters JM (2005) Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature 438:1176–1180
Fischle W, Tseng BS, Dormann HL, Ueberheide BM, Garcia BA, Shabanowitz J et al (2005) Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 438:1116–1122
Acknowledgments
Research in A.V.’s laboratory is funded by the Canadian Institutes for Health Research (CIHR, grant MOP 125916). Research in H.W.’s laboratory is funded by grants from the Canadian Institutes of Health Research (MOP 123438), and Natural Sciences and Engineering Research Council of Canada (RGPIN 435636-2013).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Guillemette, B., Hammond-Martel, I., Wurtele, H., Verreault, A. (2017). Production and Purification of Antibodies Against Histone Modifications. In: Guillemette, B., Gaudreau, L. (eds) Histones. Methods in Molecular Biology, vol 1528. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6630-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6630-1_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6628-8
Online ISBN: 978-1-4939-6630-1
eBook Packages: Springer Protocols